ClearPoint Neuro, Inc. Announces First-in-Human Cases of

SOLANA BEACH, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling company providing

FORM 10-12G

Our History

ClearPoint Neuro (Nasdaq:CLPT) - Stock Price, News & Analysis

New writeup for March 30th - by Jonah Lupton

Investor Relations :: ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro (CLPT): A Buy Based On Growing Revenues, Decreasing Cash Burn

HealthTech Industry News and Analysis

424B4

vygr-20201231x10k006.jpg

CLPT - ClearPoint Neuro - by Jonah Lupton

UroMems begins first human study of smart implant for treating SUI

Blackrock Neurotech's MoveAgain brain interface gets FDA breakthrough device designation; Commercialization planned for 2022 : r/neuralcode

ClearPoint Neuro & UCB Enter Agreement for Gene Therapies

ClearPoint Neuro wins FDA nod for ClearPoint 2.2 with Maestro Brain Modeling